Perspectives in implementing standardized case definitions for tuberculosis research involving children in a low-income, high-burden setting

Journal of Infectious Diseases

Volumn 207, Issue 5, 2013, Pages 870-871

  Holm, Line Lindebo ^a   Rose, Michala Vaaben ^b   Ravn, Pernille ^c  

^a Clinical Research Centre   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

CAUSE OF DEATH; CHILDHOOD MORTALITY; CLINICAL ASSESSMENT; DIAGNOSTIC EQUIPMENT; DISEASE CLASSIFICATION; HEALTH CARE QUALITY; HOSPITALIZED CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERFERON GAMMA RELEASE ASSAY; LETTER; LOWEST INCOME GROUP; MALNUTRITION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDIZATION; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS;

HUMANS; TUBERCULOSIS, PULMONARY;

EID: 84873619819     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis768     Document Type: Letter

References (6)

1. Graham SM, Ahmeed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis Disease. Consensus from an expert panel. J Infect Dis 2012; 205(SUPPL2):S199-208
2. Rose MV, Kimaro G, Nissen TN, et al. QuantiFERON ®-TB Gold In-Tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One 2012; 7:e37851
3. Verbal autopsy standards: Ascertaining and attributing cause of death. Geneva: WHO, 2007
4. Nissen TN, Rose MV, Kimaro G, Bygbjerg IC, Mfinanga SG, Ravn P. Challenges of loss to follow-up in tuberculosis research. PLoS One 2012; 7:e40183
5. European Centre for Disease Prevention and Control (ECDC). Use of interferon-gamma release assays in support of TB diagnosis. Stockholm: ECDC, 2011
6. World Health Organization (WHO). Use of tuberculosis interferon-gamma release assays (IGRA) in low- and middle-income countries. Geneva: WHO, 2011